Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

New treatments for male hypogonadism are effective and should be personalized.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Multiple treatments work best for hair loss.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.